Literature DB >> 32394552

Neurocognitive deficits in schizophrenia are likely to be less severe and less related to the disorder than previously thought.

Steffen Moritz1, Stephen M Silverstein2, Mona Dietrichkeit1, Jürgen Gallinat1.   

Abstract

Entities:  

Year:  2020        PMID： 32394552      PMCID： PMC7215075          DOI： 10.1002/wps.20759

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  7 in total

1.  The meaning of group differences in cognitive test performance.

Authors:  Paul M Grant; Michael W Best; Aaron T Beck
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

2.  Extent, profile and specificity of visuospatial impairment in obsessive-compulsive disorder (OCD).

Authors:  Steffen Moritz; Martin Kloss; Dirk Jacobsen; Michael Kellner; Burghard Andresen; Susanne Fricke; Georg Kerkhoff; Christina Sieman; Iver Hand
Journal:  J Clin Exp Neuropsychol       Date:  2005-10       Impact factor: 2.475

3.  Neurocognitive deficits in schizophrenia. Are we making mountains out of molehills?

Authors:  S Moritz; J P Klein; T Desler; H Lill; J Gallinat; B C Schneider
Journal:  Psychol Med       Date:  2017-05-09       Impact factor: 7.723

Review 4.  What accounts for poor functioning in people with schizophrenia: a re-evaluation of the contributions of neurocognitive v. attitudinal and motivational factors.

Authors:  Aaron T Beck; Robyn Himelstein; Keith Bredemeier; Steven M Silverstein; Paul Grant
Journal:  Psychol Med       Date:  2018-03-04       Impact factor: 7.723

5.  Meta-analysis of cognitive performance in drug-naïve patients with schizophrenia.

Authors:  Helena Fatouros-Bergman; Simon Cervenka; Lena Flyckt; Gunnar Edman; Lars Farde
Journal:  Schizophr Res       Date:  2014-07-30       Impact factor: 4.939

6.  Loneliness in psychotic disorders and its association with cognitive function and symptom profile.

Authors:  Johanna C Badcock; Sonal Shah; Andrew Mackinnon; Helen J Stain; Cherrie Galletly; Assen Jablensky; Vera A Morgan
Journal:  Schizophr Res       Date:  2015-10-31       Impact factor: 4.939

Review 7.  Nonpharmacological treatment of dyscognition in schizophrenia: effects 
of aerobic exercise
.

Authors:  Isabel Maurus; Astrid Röh; Peter Falkai; Berend Malchow; Andrea Schmitt; Alkomiet Hasan
Journal:  Dialogues Clin Neurosci       Date:  2019-09       Impact factor: 5.986
  7 in total
  14 in total

Review 1.  Gender Differences in Clinical and Psychosocial Features Among Persons With Schizophrenia: A Mini Review.

Authors:  Giulia Maria Giordano; Paola Bucci; Armida Mucci; Pasquale Pezzella; Silvana Galderisi
Journal:  Front Psychiatry       Date:  2021-12-22       Impact factor: 4.157

Review 2.  Improving Knowledge on Pathways to Functional Outcome in Schizophrenia: Main Results From the Italian Network for Research on Psychoses.

Authors:  Luigi Giuliani; Giulia Maria Giordano; Paola Bucci; Pasquale Pezzella; Francesco Brando; Silvana Galderisi
Journal:  Front Psychiatry       Date:  2021-12-14       Impact factor: 4.157

3.  Investigating the Relationship between White Matter Connectivity and Motivational Circuits in Subjects with Deficit Schizophrenia: A Diffusion Tensor Imaging (DTI) Study.

Authors:  Giulia M Giordano; Pasquale Pezzella; Mario Quarantelli; Paola Bucci; Anna Prinster; Andrea Soricelli; Andrea Perrottelli; Luigi Giuliani; Michele Fabrazzo; Silvana Galderisi
Journal:  J Clin Med       Date:  2021-12-23       Impact factor: 4.241

4.  Tracing Links Between Early Auditory Information Processing and Negative Symptoms in Schizophrenia: An ERP Study.

Authors:  Giulia M Giordano; Francesco Brando; Andrea Perrottelli; Giorgio Di Lorenzo; Alberto Siracusano; Luigi Giuliani; Pasquale Pezzella; Mario Altamura; Antonello Bellomo; Giammarco Cascino; Antonio Del Casale; Palmiero Monteleone; Maurizio Pompili; Silvana Galderisi; Mario Maj
Journal:  Front Psychiatry       Date:  2021-12-20       Impact factor: 4.157

5.  Mortality gap and physical comorbidity of people with severe mental disorders: the public health scandal.

Authors:  Andrea Fiorillo; Norman Sartorius
Journal:  Ann Gen Psychiatry       Date:  2021-12-13       Impact factor: 3.455

6.  We Should Improve Personalization of Management in Patients with a Diagnosis of Schizophrenia.

Authors:  Alfonso Tortorella
Journal:  J Clin Med       Date:  2021-12-30       Impact factor: 4.241

7.  Social Cognition Individualized Activities Lab for Social Cognition Training and Narrative Enhancement in Patients With Schizophrenia: A Randomized Controlled Study to Assess Efficacy and Generalization to Real-Life Functioning (Prot. n°: NCT05130853).

Authors:  Davide Palumbo; Edoardo Caporusso; Giuseppe Piegari; Claudio Mencacci; Sara Torriero; Luigi Giuliani; Michele Fabrazzo; Dario Pinto; Silvana Galderisi
Journal:  Front Psychiatry       Date:  2022-04-04       Impact factor: 4.157

Review 8.  Second-Generation Antipsychotics' Effectiveness and Tolerability: A Review of Real-World Studies in Patients with Schizophrenia and Related Disorders.

Authors:  Michele Fabrazzo; Salvatore Cipolla; Alessio Camerlengo; Francesco Perris; Francesco Catapano
Journal:  J Clin Med       Date:  2022-08-03       Impact factor: 4.964

9.  Mismatch Negativity and P3a Impairment through Different Phases of Schizophrenia and Their Association with Real-Life Functioning.

Authors:  Giulia M Giordano; Luigi Giuliani; Andrea Perrottelli; Paola Bucci; Giorgio Di Lorenzo; Alberto Siracusano; Francesco Brando; Pasquale Pezzella; Michele Fabrazzo; Mario Altamura; Antonello Bellomo; Giammarco Cascino; Anna Comparelli; Palmiero Monteleone; Maurizio Pompili; Silvana Galderisi; Mario Maj
Journal:  J Clin Med       Date:  2021-12-13       Impact factor: 4.241

10.  Investigating the Relationships of P3b with Negative Symptoms and Neurocognition in Subjects with Chronic Schizophrenia.

Authors:  Giulia M Giordano; Andrea Perrottelli; Armida Mucci; Giorgio Di Lorenzo; Mario Altamura; Antonello Bellomo; Roberto Brugnoli; Giulio Corrivetti; Paolo Girardi; Palmiero Monteleone; Cinzia Niolu; Silvana Galderisi; Mario Maj
Journal:  Brain Sci       Date:  2021-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.